FDA Approves Bausch + Lomb TRULIGN Astigmatism Correction Lens

Bausch + Lomb, global ophthalmic-focused company, has earned FDA approval for its TRULIGN Toric intraocular lens.

The TRULIGN is designed to correct astigmatism and to improve vision across a natural range of focus.

More Articles on Ophthalmology:
Dr. David Vollman Heads VA Cataract Surgery Outcomes Data Collection
Dr. Eva Liang Opens Center for Sight in Las Vegas
Dr. Thomas Findlan Plans New Freestanding Pittsburgh Eye Location


Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast